Impact of Perineural Invasion in the Pathologically N0 Neck in Oral Cavity Squamous Cell Carcinoma
Overview
Otorhinolaryngology
Authors
Affiliations
Objective: Patients with oral cavity squamous cell carcinoma (OCSCC) undergo adjuvant radiation for pathologically high-risk features including positive nodal disease and extracapsular spread (ECS). In the absence of these high-risk features, our objective was to determine if perineural invasion (PNI) is an independent risk factor and if adjuvant radiation (XRT) improves disease control rates.
Study Design: Historical cohort analysis.
Setting: Tertiary university hospital.
Methods: Eighty-eight OCSCC patients (46 males, 42 females; mean age = 56.7 years; median follow-up = 4.6 years) treated surgically with pathologically N0 (pN0) necks were studied. Overall, 23% (20/88) were pN0/PNI+ and of those with PNI, 70% (14/20) underwent XRT. Survival analysis using Kaplan-Meier followed by multivariable Cox models was performed.
Results: Multivariate analysis verified PNI to be associated with worse disease-free interval (DFI) (P = .012) and local-regional control (LRC) (P = .005) and perivascular invasion (PVI) associated with worse DFI (P = .05). Among pN0/PNI+ patients, those who received XRT demonstrated significantly improved DFI (mean = 6.5 years vs 1.7 years; P = .014) and LRC (mean 6.7 years vs 1.9 years; P = .047). There was no improvement in overall survival (P = .68) or disease-specific survival (P = .8) in those receiving XRT.
Conclusions: PNI is an independent adverse risk factor in the absence of nodal metastasis and extracapsular spread. We observed a statistically significantly longer DFI and LRC when patients were treated with adjuvant radiation.
Cheng H, Lin L, Lin H, Liu C J Otolaryngol Head Neck Surg. 2025; 54:19160216251316219.
PMID: 39902557 PMC: 11792026. DOI: 10.1177/19160216251316219.
Alqutub S, Alqutub A, Bakhshwin A, Mofti Z, Alqutub S, Alkhamesi A Front Oncol. 2024; 14:1401211.
PMID: 38835393 PMC: 11148647. DOI: 10.3389/fonc.2024.1401211.
Wang W, Wang Y, Zeng W, Xie X, Li C, Zhou Q Cancer Med. 2024; 13(3):e7016.
PMID: 38400675 PMC: 10891452. DOI: 10.1002/cam4.7016.
Prognostic Value of Anteroposterior Extension in Oral Tongue and Floor Squamous Cell Carcinoma.
Contro G, Sordi A, Taboni S, Citterio M, Ruaro A, de Lucia G JAMA Otolaryngol Head Neck Surg. 2023; 150(2):142-150.
PMID: 38153706 PMC: 10853838. DOI: 10.1001/jamaoto.2023.3809.
Binmadi N, Alsharif M, Almazrooa S, Aljohani S, Akeel S, Osailan S Diagnostics (Basel). 2023; 13(21).
PMID: 37958235 PMC: 10649820. DOI: 10.3390/diagnostics13213339.